US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

166.24

+13.698.97%

Volume:380.17K

Turnover:61.70M

Market Cap:810.33M

PE:- -

High:166.42

Open:155.28

Low:155.21

Close:152.55

52wk High:176.44

52wk Low:32.55

Shares:4.87M

Float Shares:4.87M

Volume Ratio:2.07

T/O Rate:7.80%

Dividend:0.43

Dividend Rate:0.26%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Does Rising Cash Flow Justify HCA Healthcare’s 2025 Share Price Surge?

Simply Wall St.

Republicans Relive Healthcare Nightmare as Midterms Loom -- WSJ

FTC Release: FTC Bureau of Competition Statement on Termination of Healthcare Managed Services Merger

Rival Healthcare Proposals Fail in Senate -- WSJ

Sector Update: Health Care Stocks Edge Higher Premarket Friday

MT Newswires Live

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

Does Regis’ A$25m Regional Aged Care Sell‑Off Shift The Bull Case For Regis Healthcare (ASX:REG)?

Simply Wall St.

Humanwell Healthcare Gets German Approval for Midazolam Injection

MT Newswires Live

Chinese Healthcare Firms Poised to Continue Out-Licensing Deals in 2026 -- Market Talk

Sigma Healthcare Selloff Attracts New Bulls -- Market Talk

Does Molina Healthcare’s 2025 Valuation Reflect Its Sharp Share Price Decline and Rebound?

Simply Wall St.

Senate Bills on Healthcare Subsidies Are Likely to Fail. Why There's Still Hope for a Deal. -- Barrons.com

Sector Update: Health Care Stocks Mixed Premarket Thursday

MT Newswires Live

Accenture Invests in Healthcare Technology Firm Ryght AI to Accelerate Drug Development

MT Newswires Live

SEALSQ Enters the Healthcare Industry Through IC’Alps, Delivering Custom Integrated Chip Solutions and Post-Quantum Protection for Next-Generation Medical Devices

Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference

Showdown Over Healthcare Vote Is a Sign of What's to Come -- WSJ

OMRON Healthcare Unveils Global ECG Strategy

Some Republicans Break With Leaders in Healthcare Fight -- WSJ

Did HCA’s (HCA) Nursing Investment and FTC Scrutiny Just Reframe Its Labor Strategy Narrative?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LABU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":166.24,"timestamp":1766163122671,"preClose":152.55,"halted":0,"volume":380170,"delay":0,"floatShares":4874486,"shares":4874486,"eps":0,"marketStatus":"Trading","change":13.69,"latestTime":"12-19 11:52:14 EST","open":155.28,"high":166.4237,"low":155.21,"amount":61699933.458799995,"amplitude":0.073508,"askPrice":166.47,"askSize":310,"bidPrice":166.08,"bidSize":100,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766178000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":152.55,"sharesOutstanding":4874486,"nav":155.953,"aum":760189675.99,"dividendRate":0.002569,"bidAskSpread":0.002334,"preHourTrading":{"tag":"盘前","latestPrice":154.9493,"preClose":152.55,"latestTime":"09:23 EST","volume":2158,"amount":333483.1851,"timestamp":1766154211777},"postHourTrading":{"tag":"盘后","latestPrice":152,"preClose":152.55,"latestTime":"19:59 EST","volume":2119,"amount":322472.5255,"timestamp":1766105971851},"volumeRatio":2.072416,"impliedVol":0.8031,"impliedVolPercentile":0.188},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":4874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.072416,"shares":4874486,"dividePrice":0.4271,"high":166.4237,"amplitude":0.073508,"preClose":152.55,"low":155.21,"week52Low":32.55,"pbRate":"--","week52High":176.44,"institutionHeld":0,"latestPrice":166.24,"committee":-0.512195,"eps":0,"divideRate":0.002569,"volume":380170,"delay":0,"ttmEps":0,"open":155.28,"prevYearClose":90,"prevWeekClose":164.81,"prevMonthClose":166.65,"prevQuarterClose":93.61,"fiveDayClose":164.81,"twentyDayClose":132.83,"sixtyDayClose":82.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591658514","title":"Does Rising Cash Flow Justify HCA Healthcare’s 2025 Share Price Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591658514","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591658514?lang=en_us&edition=fundamental","pubTime":"2025-12-13 23:34","pubTimestamp":1765640050,"startTime":"0","endTime":"0","summary":"If you are wondering whether HCA Healthcare is still worth buying after such a large share price rise, or if the easy money has already been made, this article will walk through whether the current price still stacks up against its fundamentals.\nDespite a small dip of 0.4% over the last week, HCA shares are up 2.4% over 30 days, 62.8% year to date, 55.3% over 1 year, 107.5% over 3 years, and 207.6% over 5 years, which naturally raises the question of how much upside is left from here.\nRecent...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/261825-main-header/1756254640157","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/261825-main-header/1756254640157"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hca/hca-healthcare/news/does-rising-cash-flow-justify-hca-healthcares-2025-share-pri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hca/hca-healthcare/news/does-rising-cash-flow-justify-hca-healthcares-2025-share-pri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0708994859.HKD","LU1084165304.USD","DCF","BK4581","LABU","LU0868494617.USD","LU0203345920.USD","LU1150488218.USD","BK4585","LU0310799852.SGD","LU1267930490.SGD","LU1150488135.SGD","LU1267930573.SGD","LU0433182093.SGD","LU0128525929.USD","LU0114720955.EUR","LU0878866978.SGD","LU0130102774.USD","LU0187121727.USD","LU0068578508.USD","LU0211327993.USD","LU0203347892.USD","LU0980610538.SGD","LU0985489474.SGD","HCA","LU1201861249.SGD","BK4588","IE00B3S45H60.SGD","LU0211328371.USD","BK4185","LU0029864427.USD","SG9999014021.USD","IE00B775SV38.USD","LU1261432733.SGD","LU1489326972.SGD","XLV","LU2244417387.USD","LU0648001328.SGD","LU1119994496.HKD","SG9999014039.USD","LU0882574055.USD","XBI","BK4504","SG9999014005.SGD","SG9999014013.SGD","LU0310800379.SGD"],"gpt_icon":0},{"id":"2591358506","title":"Republicans Relive Healthcare Nightmare as Midterms Loom -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2591358506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591358506?lang=en_us&edition=fundamental","pubTime":"2025-12-13 12:00","pubTimestamp":1765598400,"startTime":"0","endTime":"0","summary":"Republicans suffered through a recurring nightmare this week: their inability to replace or at least unwind the Affordable Care Act, President Barack Obama's signature healthcare program.For the past decade, President Trump and the party have raged against the 2010 law, only to see legislative attempts to decouple it from the American economy fail. This week was no different, as a Republican proposal to replace ACA subsidies with sending federal funds directly to some households for out-of-pocket healthcare costs failed to advance in the Republican-controlled Senate.For some Republican lawmakers, a sense of déjà vu took hold this past week amid worries that the issue might once again cost the party its political majorities.\"We run on this every time, there's not an election that comes up where we don't get beat up on healthcare,\" said Rep. Jen Kiggans, a Virginia Republican facing one of the most competitive races next year who has led a bipartisan effort to extend the subsidies for on","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU0029874061.USD","HCSG","XBI","BK4581","BK4137","LU0128526141.USD","XLV","LABU"],"gpt_icon":0},{"id":"2591068989","title":"FTC Release: FTC Bureau of Competition Statement on Termination of Healthcare Managed Services Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2591068989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591068989?lang=en_us&edition=fundamental","pubTime":"2025-12-13 04:10","pubTimestamp":1765570200,"startTime":"0","endTime":"0","summary":"In response to yesterday's announcement that Aya Healthcare terminated its proposed acquisition of Cross Country Healthcare, Federal Trade Commission Bureau of Competition Director Daniel Guarnera issued the following statement:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTC","XLV","BK4588","LU0128526141.USD","BK4137","LABU","HCSG","BK4581","BK4585","XBI","LU0029874061.USD"],"gpt_icon":0},{"id":"2590507852","title":"Rival Healthcare Proposals Fail in Senate -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2590507852","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590507852?lang=en_us&edition=fundamental","pubTime":"2025-12-12 22:55","pubTimestamp":1765551300,"startTime":"0","endTime":"0","summary":"This is an edition of the WSJ Health newsletter, a weekly briefing on what's new in health, medicine, personal well-being and the business of healthcare. If you're not subscribed, sign up here.A Democratic proposal to extend enhanced ACA subsidies failed in the Senate. Republicans put forward an alternative healthcare bill that would instead fund individual health accounts for some households. That also failed. It's just weeks to go until millions of Americans covered under the Affordable Care Act face soaring costs for their coverage when the subsidies lapse.Drugmakers are ditching middlemen to sell directly to patients. The shift is a huge departure from how pharma companies have sold drugs for decades and threatens the multibillion-dollar business of firms that have traditionally filled prescriptions. It's also saving some patients hundreds of dollars off the cost of prescriptions.Vaccines could boost your health in unexpected ways. As doctors and vaccine deniers spar over the safet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BK4W5M84.HKD","LU1069344957.HKD","LU1623119135.USD","BK4137","LU2237443549.SGD","LU0823416689.USD","LU0683600562.USD","SGXZ81514606.USD","LU0316494557.USD","IE00BJJMRZ35.SGD","LU0106261372.USD","LU0096364046.USD","LU2471134879.HKD","LABU","LU2168564495.EUR","LU2361044949.HKD","LU2361045086.USD","LU2417539215.USD","LU0094547139.USD","HCSG","IE00B7KXQ091.USD","LU0672654240.SGD","LU0323591593.USD","LU2237443895.HKD","LU2168564149.EUR","LU2112291526.USD","XLV","LU0097036916.USD","IE00BKPKM429.USD","LU0256863902.USD","LU2468319806.SGD","LU0354030511.USD","LU2106854487.HKD","LU2357305700.SGD","LU2750360997.AUD","SG9999017495.SGD","LLY","LU2324357040.USD","XBI","SG9999013999.USD","SG9999014898.SGD","LU0456855351.SGD","GB00BDT5M118.USD","IE00BFSS8Q28.SGD","LU2236285917.USD","LU1061106388.HKD","LU1035775433.USD","LU1064131342.USD","LU0266013472.USD","LU2491050071.SGD"],"gpt_icon":0},{"id":"2590047895","title":"Sector Update: Health Care Stocks Edge Higher Premarket Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2590047895","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590047895?lang=en_us&edition=fundamental","pubTime":"2025-12-12 22:18","pubTimestamp":1765549108,"startTime":"0","endTime":"0","summary":"Health care stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF  advancing by 0.6% and the iShares Biotechnology ETF  up 0.1%.Relay Therapeutics  shares were up more than 11% after the company said interim results from a study of zovegalisib plus fulvestrant to treat breast cancer patients showed \"robust activity.\"ImmunityBio  stock was up more than 4% after the company said the European Medicines Agency has recommended granting a conditional marketing authorization for anktiva in combination with BCG for the treatment of BGC-unresponsive non-muscle invasive bladder cancer.BioCryst Pharmaceuticals  shares were up more than 2% after the company said the US Food and Drug Administration approved Orladeyo oral pellets to help prevent hereditary angioedema attacks in children ages 2 to under 12.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","XLV","BK4581","BK4588","BCRX","BK4563","IBB","BK4585","BK4139","XBI","RLAY","BK4547","IBRX"],"gpt_icon":0},{"id":"2590505211","title":"Option Care Health to Participate in the J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505211","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505211?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:00","pubTimestamp":1765540800,"startTime":"0","endTime":"0","summary":"BANNOCKBURN, Ill., Dec.  12, 2025  (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion ser","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/12/3204556/0/en/Option-Care-Health-to-Participate-in-the-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU1668664300.SGD","IE00BKVL7J92.USD","LU0320765646.SGD","LU1162221912.USD","LU2089284900.SGD","BK4516","LU0267386448.USD","BK4588","BK4534","LU1732800096.USD","LU0029874061.USD","LU1363072403.SGD","BK4504","LU0006306889.USD","LU0557290698.USD","XLV","LU2111349929.HKD","LU1791710582.SGD","LU2028103732.USD","BK4137","BK4127","LU2023251221.USD","LU1989772840.SGD","LU1720051108.HKD","LU0225283273.USD","LU1074936037.SGD","LABU","LU1244550494.USD","LU0528227936.USD","LU0795875169.SGD","LU1989772923.USD","LU0795875086.SGD","XBI","LU0106831901.USD","LU1244550577.SGD","LU0971096721.USD","LU1548497426.USD","IE00BZ1G4Q59.USD","LU1791710400.SGD","LU0098860793.USD","HCSG","LU0882574139.USD","BK4585","LU0106261372.USD","LU2133065610.SGD","LU1732799900.SGD","LU0158827948.USD","LU2347655156.SGD","LU2271345857.HKD"],"gpt_icon":0},{"id":"2591268642","title":"Does Regis’ A$25m Regional Aged Care Sell‑Off Shift The Bull Case For Regis Healthcare (ASX:REG)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591268642","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591268642?lang=en_us&edition=fundamental","pubTime":"2025-12-12 19:26","pubTimestamp":1765538816,"startTime":"0","endTime":"0","summary":"Regis Healthcare has sold its Ayr and Home Hill aged care homes in Far North Queensland to Ozcare, crystallising an expected one-off pre-tax gain of about A$25 million in FY26 and reducing its regional bed count by 156. \nThis divestment marks a shift toward a leaner, city-focused portfolio that analysts suggest could support more efficient operations and improved margins. \nNext, we’ll examine how Regis’ move away from regional beds toward higher-efficiency metropolitan facilities could...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/does-regis-a25m-regional-aged-care-selloff-shift-the-bull-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/does-regis-a25m-regional-aged-care-selloff-shift-the-bull-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4080","BK7113","XBI","BK4231","BK4585","REG.AU","REG","LABU","XLV","BK4581"],"gpt_icon":0},{"id":"2590578881","title":"Humanwell Healthcare Gets German Approval for Midazolam Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2590578881","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590578881?lang=en_us&edition=fundamental","pubTime":"2025-12-12 14:24","pubTimestamp":1765520675,"startTime":"0","endTime":"0","summary":"Humanwell Healthcare  80%-owned Yichang Renfu obtained marketing approval for its midazolam injection issued by the German Federal Institute for Drugs and Medical Devices.The approval allows for the sale of multiple midazolam formulations for sedation, anesthesia support and intensive care unit use, according to a Friday filing with the Shanghai bourse.Shares of the pharmaceutical company were down 2% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","BK0096","BK0239","BK4581","BK0185","HCSG","LU0029874061.USD","BK4588","BK0012","BK4137","XLV","LABU","BK0028","BK4585","XBI","LU0128526141.USD","600079","BK0070"],"gpt_icon":0},{"id":"2590155522","title":"Chinese Healthcare Firms Poised to Continue Out-Licensing Deals in 2026 -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2590155522","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590155522?lang=en_us&edition=fundamental","pubTime":"2025-12-12 12:42","pubTimestamp":1765514520,"startTime":"0","endTime":"0","summary":"0442 GMT - China's healthcare sector is likely to see continued out-licensing activity in 2026, though the markets may become more rational about the sector, Deutsche Bank analyst Cyrus Ng says in a note. He notes that China, which accounts for 11%-13% of global R&D drug spending yet contributes roughly 40% of innovative drugs in clinical development, will remain a key source of high-potential, low-cost pharma assets for global drugmakers. Still, the timing, size, partners, and cooperation model of out-licensing deals remain highly unpredictable, Ng says, adding that markets will start to view them as positive surprises rather than probable events. He expects investors should refocus on company fundamentals next year as more companies reach profitability amid an improving funding environment and a supportive policy landscape.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XBI","BK4137","XLV","LU0128526141.USD","HCSG","LU0029874061.USD","BK4588","BK4581","LABU"],"gpt_icon":0},{"id":"2590754024","title":"Sigma Healthcare Selloff Attracts New Bulls -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2590754024","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590754024?lang=en_us&edition=fundamental","pubTime":"2025-12-12 08:20","pubTimestamp":1765498800,"startTime":"0","endTime":"0","summary":"0020 GMT - Sigma Healthcare gets a new pair of new bulls at Morgans, where analysts see the pharmaceutical retailer and supplier as one of Australia's highest growth health stocks. Analysts Scott Power and Emily Porter raise their recommendation to buy from accumulate on recent share-price weakness, telling clients in a note that they still forecast consistent EPS growth of about 20% over the next three years. They don't envisage any problems from union negotiations and expect an agreement on terms for employees at its Chemist Warehouse retail chain. Management's focus on integrating the Chemist Warehouse and supply businesses support the analysts' confidence in revenue and earnings growth. Morgans has a A$3.39 target price on the stock, which is up 0.9% at A$2.905. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","LU0128526141.USD","LABU","LU0029874061.USD","BK4585","BK4588","XLV","XBI","BK7103","HCSG","BK4581","SIG.AU"],"gpt_icon":0},{"id":"2590474515","title":"Does Molina Healthcare’s 2025 Valuation Reflect Its Sharp Share Price Decline and Rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590474515","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590474515?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:37","pubTimestamp":1765489033,"startTime":"0","endTime":"0","summary":"If you are wondering whether Molina Healthcare is a quietly compelling value play or a stock to avoid at current levels, you are not alone. This article is going to unpack that in plain English.\nAfter falling sharply over the longer term, with the share price down 44.1% year to date and 46.5% over the last year, the stock has recently bounced with a 7.7% gain over the past week and 13.9% over the last 30 days from a last close of $160.52.\nMuch of the recent price action has been driven by...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-moh/molina-healthcare/news/does-molina-healthcares-2025-valuation-reflect-its-sharp-sha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-moh/molina-healthcare/news/does-molina-healthcares-2025-valuation-reflect-its-sharp-sha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XLV","BK4532","BK4581","BK4154","XBI","DCF","SG9999014005.SGD","SG9999014039.USD","MOH","SG9999014013.SGD","BK4588","SG9999014021.USD","LABU","BK4585"],"gpt_icon":0},{"id":"2590375548","title":"Senate Bills on Healthcare Subsidies Are Likely to Fail. Why There's Still Hope for a Deal. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2590375548","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590375548?lang=en_us&edition=fundamental","pubTime":"2025-12-12 00:50","pubTimestamp":1765471800,"startTime":"0","endTime":"0","summary":"Two bills aimed at lowering healthcare costs for more than 20 million Americans currently enrolled in Obamacare health plans are expected to fail in the Senate on Thursday. But there's more movement behind the scenes that could eventually provide some relief.The first vote will be on a Republican plan aimed at replacing monthly premium subsidies with direct deposits into health savings accounts, which enrollees can use to cover out-of-pocket costs.Brought by Louisiana Sen. Bill Cassidy and Idaho Sen. Mike Crapo, the Health Care Freedom for Patients Act would deposit either $1,000 or $1,500 in the accounts per person for households with incomes of up to 700% of the federal poverty level. It also reduces Medicaid funding for states through stricter eligibility requirements and prohibits HSA funds from being used for abortion or gender transition services.How that shapes up is yet to be seen, but the flurry of proposals in both chambers of Congress indicates that some kind of relief from ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","LU0128526141.USD","XBI","XLV","BK4581","HCSG","BK4137","BK4585","LU0029874061.USD","HOPE","BK4588","BK4211"],"gpt_icon":0},{"id":"2590511214","title":"Sector Update: Health Care Stocks Mixed Premarket Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2590511214","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590511214?lang=en_us&edition=fundamental","pubTime":"2025-12-11 22:18","pubTimestamp":1765462684,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Thursday, with the State Street Health Care Select Sector SPDR ETF  up 0.3% and the iShares Biotechnology ETF  0.2% lower.Rezolute  shares were down more than 88% after the company said its phase 3 sunRIZE study evaluating ersodetug in patients with congenital hyperinsulinism did not meet its primary and key secondary endpoints.Sarepta Therapeutics  stock was down nearly 7% after the company said it has negotiated exchange agreements with a limited number of holders of its 1.25% convertible senior notes due 2027.IDEAYA Biosciences  shares were up nearly 3% after the company said it has completed its targeted full enrollment of 435 patients in the phase 2/3 trial evaluating darovasertib in combination with Pfizer's  crizotinib for the treatment of metastatic uveal melanoma, a form of ocular cancer.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","BK4592","IE00BBT3K403.USD","BK4550","SG9999002232.USD","BK7095","LU0306806265.USD","XBI","IE00BLSP4239.USD","LU0985481810.HKD","LU0234572021.USD","BK4139","SG9999003800.SGD","IE0002141913.USD","LU0225771236.USD","IE00B19Z3B42.SGD","SG9999013999.USD","IE00BJJMRZ35.SGD","BK4599","LU0058720904.USD","IE0009355771.USD","SG9999001176.SGD","LU0868494617.USD","LU0321505439.SGD","IDYA","LU1894683348.USD","LU1894683264.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU1883839398.USD","SG9999002224.SGD","RZLT","IE00B2B36J28.USD","SG9999011175.SGD","LU1066053197.SGD","LU1023059063.AUD","BK4533","BK4581","LU1057294990.SGD","BK4534","IE00BFTCPJ56.SGD","LU0321505868.SGD","BK4588","LU0122379950.USD","BK4007","IE0002270589.USD","LU0306807586.USD","IE00B19Z3581.USD","LU0170899867.USD","IE000M9KFDE8.USD","SRPT","LU0289739699.SGD","LU1066051498.USD","LU0456855351.SGD","LU0225284248.USD","LABU","SG9999001176.USD","BK4585","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2590519220","title":"Accenture Invests in Healthcare Technology Firm Ryght AI to Accelerate Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2590519220","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590519220?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:57","pubTimestamp":1765461422,"startTime":"0","endTime":"0","summary":"Accenture (ACN) said Thursday it has invested in healthcare technology firm Ryght AI, aiming to combine agentic AI with enterprise technology to accelerate drug development.Terms of the investment wer","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4543","LU1366333091.USD","LU0661504455.SGD","LU0868494708.USD","LU1989772923.USD","LU0545039389.USD","LU0289961442.SGD","BK4134","LU1032466523.USD","AAQC","LU1003077747.HKD","LU1506573853.SGD","SG9999014898.SGD","SG9999014906.USD","SG9999017495.SGD","LU0323240290.USD","SG9999018857.SGD","SG9999004303.SGD","LU1116320737.USD","LU0949170772.SGD","XLV","LU0265550359.USD","XBI","IE00BJJMRX11.SGD","LU0265550946.USD","LU0128526141.USD","SGXZ23171101.USD","ACN","BK4561","LU0553294199.USD","SG9999018865.SGD","IE00BHPRN162.USD","BK4551","BK4585","IE00BSNM7G36.USD","AI","BK4023","LU0157215616.USD","LU0342679015.USD","BK4137","LU1823568750.SGD","LU1116320901.HKD","BK4588","BK4581","HCSG","LU0545562505.USD","SG9999014914.USD","BK4587","IE00BJJMRY28.SGD"],"gpt_icon":0},{"id":"2590751942","title":"SEALSQ Enters the Healthcare Industry Through IC’Alps, Delivering Custom Integrated Chip Solutions and Post-Quantum Protection for Next-Generation Medical Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=2590751942","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590751942?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:45","pubTimestamp":1765460700,"startTime":"0","endTime":"0","summary":"Last but not least, the team is also involved in the ambitious Ze[US] France2030 project to make in real time the invisible visible in the human body.Discover details on French government, Inserm foundation, Physical for Medicine Paris, and involved partners web sites and communications. Post-Quantum Protection: A New Standard for Healthcare CybersecurityThe heal","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3203926/0/en/SEALSQ-Enters-the-Healthcare-Industry-Through-IC-Alps-Delivering-Custom-Integrated-Chip-Solutions-and-Post-Quantum-Protection-for-Next-Generation-Medical-Devices.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POST","BK4137","HCSG","LU0029874061.USD","LU0128526141.USD","BK4585","BK4581","BK4212","XBI","BK4588","XLV","LAES","BK4141","ECC","LABU"],"gpt_icon":0},{"id":"2590513409","title":"Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2590513409","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590513409?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:00","pubTimestamp":1765454400,"startTime":"0","endTime":"0","summary":"RESEARCH TRIANGLE PARK, N.C., Dec.  11, 2025  (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene thera","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3203756/0/en/Opus-Genetics-to-Present-at-the-J-P-Morgan-2026-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0158827781.USD","BK4581","LABU","LU1244550494.USD","LU2111349929.HKD","LU1989772840.SGD","LU1720051108.HKD","LU0882574139.USD","BK4585","LU2089283258.USD","LU0225283273.USD","BK4127","LU0128526141.USD","LU0557290698.USD","IE00BZ1G4Q59.USD","LU2089284900.SGD","LU0106261372.USD","LU2133065610.SGD","LU2028103732.USD","LU0098860793.USD","LU1548497426.USD","LU0971096721.USD","LU0267386448.USD","LU2347655156.SGD","LU0158827948.USD","BK4516","LU1162221912.USD","BK4534","LU0106831901.USD","LU1668664300.SGD","LU1791710400.SGD","LU0795875086.SGD","LU0795875169.SGD","XLV","LU0006306889.USD","LU1720051017.SGD","LU0912757837.SGD","LU0314104364.USD","LU0320765646.SGD","LU2357305700.SGD","LU1732799900.SGD","LU1732800096.USD","BK4137","XBI","HCSG","LU0234570918.USD","LU1791710582.SGD","LU1244550221.USD","LU0528227936.USD","LU1989772923.USD"],"gpt_icon":0},{"id":"2590518525","title":"Showdown Over Healthcare Vote Is a Sign of What's to Come -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2590518525","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590518525?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:56","pubTimestamp":1765454160,"startTime":"0","endTime":"0","summary":"Good morning. Oftentimes lawmakers will pass a bill that creates a program that expires, and then the expiration of that program ticks like a bomb, creating more panic as the deadline nears.Healthcare subsidies created by Democrats in 2021 expire at the end of this year.The Senate is split. Republican leaders are advancing a plan that would create health savings accounts to offset healthcare costs, while Democrats -- and some Republicans -- want to temporarily extend the existing subsidies. In a moment when voters appear quite frustrated about costs and affordability, this has become a big political and economic dilemma.The president is using his power of pardon very differently during his second term. Most occupants of the White House, including Trump in his first term, typically hand out pardons at the end of their first four years. Trump has already issued a wave of pardons so far in the first year of his second term.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4581","XLV","BK4137","LU0128526141.USD","XBI","LU0029874061.USD","HCSG","LABU"],"gpt_icon":0},{"id":"2590567719","title":"OMRON Healthcare Unveils Global ECG Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2590567719","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590567719?lang=en_us&edition=fundamental","pubTime":"2025-12-11 15:00","pubTimestamp":1765436400,"startTime":"0","endTime":"0","summary":"New services and strategic partnerships advance Going for ZERO visionTOKYO, Dec. 11, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. announced new initiatives to accelerate its global electrocardiogram  business strategy, positioning it as a key driver of the company's cardiovascular vision, Going for ZERO. The strategy, first presented at a press conference held in Tokyo on November 12, 2025, includes additional investment in Indian AI healthtech company Tricog Health India Private Limited and the planned transfer of the Heartnote ECG service business from JSR Corporation.\"Confronting the heart failure 'pandemic' and the shortage of cardiovascular specialists requires new approaches,\" said Ayumu Okada, President and CEO, OMRON Healthcare Co., Ltd. \"By combining innovative technology with strategic partnerships, we aim to take our cardiovascular business to the next stage and help prevent serious cardiac events before they occur.\"","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2843331/Speakers_OMRON_HEALTHCARE_press_conference_November_12_2025.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2843331/Speakers_OMRON_HEALTHCARE_press_conference_November_12_2025.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/omron-healthcare-unveils-global-ecg-strategy-302638788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","ECG.AU","BK7064","BK4137","BK4588","CFA.SI","ECG","XBI","XLV","BK4129","LU0029874061.USD","LU0128526141.USD","HCSG","BK4585","BK4581"],"gpt_icon":0},{"id":"2590964555","title":"Some Republicans Break With Leaders in Healthcare Fight -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2590964555","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590964555?lang=en_us&edition=fundamental","pubTime":"2025-12-11 06:01","pubTimestamp":1765404060,"startTime":"0","endTime":"0","summary":"WASHINGTON -- A growing chunk of Republicans in both the House and Senate are breaking with party leaders and saying the GOP should extend expiring Affordable Care Act subsidies, seeing that as the only way to avert big cost increases for 20 million households next year and buy time for a bigger overhaul.Republicans have fought for years to stop or curtail the 2010 health law, casting it as a failed program that props up big health insurers and fuels cost increases. But with enhanced ACA subsidies set to lapse next year, some Republicans across the political spectrum say they are willing to back a short-term extension.\"I'd be open to doing it in the short-term until we fix the overall problem,\" said Rep. Ronny Jackson , President Trump's former White House physician. \"I'd be willing to do it to bridge a gap.\". Trump has heavily criticized the ACA and said he would favor direct payments to Americans, but he hasn't put forward his own plan. Johnson had","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4137","LU0128526141.USD","XBI","LABU","BK4581","LU0029874061.USD","BK4585","HCSG","XLV"],"gpt_icon":0},{"id":"2590177532","title":"Did HCA’s (HCA) Nursing Investment and FTC Scrutiny Just Reframe Its Labor Strategy Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590177532","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590177532?lang=en_us&edition=fundamental","pubTime":"2025-12-11 01:16","pubTimestamp":1765386972,"startTime":"0","endTime":"0","summary":"In recent days, HCA Healthcare announced a US$4.8 million commitment to Pepperdine University’s new School of Nursing and received a Federal Trade Commission letter cautioning against anticompetitive employment practices in healthcare labor contracts.\nThese developments highlight how HCA is simultaneously investing in expanding the nursing workforce while facing closer regulatory attention on how it competes for clinical talent.\nWe’ll now examine how HCA’s nursing education investment and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/261825-main-header/1756254640157","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/261825-main-header/1756254640157"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hca/hca-healthcare/news/did-hcas-hca-nursing-investment-and-ftc-scrutiny-just-refram","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hca/hca-healthcare/news/did-hcas-hca-nursing-investment-and-ftc-scrutiny-just-refram","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1150488135.SGD","SG9999014039.USD","LU1201861249.SGD","LU0882574055.USD","LU2244417387.USD","LU1267930490.SGD","HCA","IE00B3S45H60.SGD","BK4588","LU0985489474.SGD","LU1119994496.HKD","LU0203347892.USD","LU0868494617.USD","LU0310799852.SGD","LU0130102774.USD","LU0708994859.HKD","BK4581","LU0187121727.USD","LU0029864427.USD","XLV","LU0114720955.EUR","LU0211328371.USD","LU0310800379.SGD","BK4504","LU1261432733.SGD","SG9999014013.SGD","LU1267930573.SGD","SG9999014021.USD","IE00B775SV38.USD","LU0980610538.SGD","LU0648001328.SGD","BK4185","LU1489326972.SGD","LU0203345920.USD","LU0878866978.SGD","SG9999014005.SGD","LU1150488218.USD","LU0128525929.USD","FTC","LU0068578508.USD","LABU","LU0211327993.USD","LU1084165304.USD","LU0433182093.SGD","BK4585","XBI"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}